Title: Development and Validation of a PK Method for Tocilizumab in Both Singlicate and Duplicate on the Gyrolab Platform
Morgan Evans, Principal Method Development Scientist – Immunoassay at Agilex Biolabs, will be presenting on development and validation of a tocilizumab PK method in both singlicate and duplicate at the 13th EBF open symposium. He will be presenting on the third day of the conference (19th Nov 2020) between 16:00 and 17:30 CET. Morgan will briefly summarise the poster with a 5-minute presentation and welcomes you to participate in the questions and answers. Learn more here
